Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19

Dec 19, 2024 - 06:00

Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19

Read the original article

Tags:

Previous Article

Abera and Orexo partner for vaccine powder formulations

Oncology R&D: emerging therapies and new challenges

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Humana projects a tough road for Medicare Advantage, sinking its stock

STAT+: Humana projects a tough road for Medicare Advant...

Jan 26, 2024

Babies born to opioid users have shorter hospital stays with parental involvement: study

Babies born to opioid users have shorter hospital stays...

May 1, 2023

Agios sells vorasidenib US royalties for $905m

Agios sells vorasidenib US royalties for $905m

May 31, 2024